Company research / KRMD

KORU Medical Systems, Inc. (KRMD)

CIK 0000704440 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends around Dec 31

For the year ended 2025-12-31, KORU Medical Systems, Inc. reported revenue of $41.13M. Revenue grew 22.2% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $45.11M.

Key ratios (year ended 2025-12-31)

62.3%
Gross margin
-7.2%
Operating margin
-6.4%
Net margin
-15.5%
Return on year-end equity
22.2%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-01

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30
2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312017-02-28
Revenue$45.11M$41.13M$33.65M$28.52M$27.90M$23.49M$24.18M$23.16M$17.35Mn/an/a
Cost of Revenue$16.95M$15.52M$12.31M$11.81M$12.53M$9.72M$9.24M$8.31M$6.54Mn/an/a
Gross Profit$28.16M$25.60M$21.33M$16.71M$15.37M$13.77M$14.94M$14.85M$10.81Mn/a$7.57M
R&D Expense$4.46M$4.39M$5.26M$5.74M$4.96M$2.47M$1.30M$740.5K$241.1Kn/a$237.5K
Operating Income-$1.65M-$2.97M-$6.45M-$10.27M-$10.78M-$7.03M-$1.25M$585.7K$1.16Mn/a-$736.3K
Depreciation & Amortization$791.2K$810.5K$888.5K$870.4K$587.1K$463.1K$418.6K$340.2K$309.3Kn/a$300.6K
EBITDA-$861.5K-$2.16M-$5.56M-$9.40M-$10.19M-$6.57M-$836.2K$925.9K$1.47Mn/a-$435.6K
Net Incomen/a-$2.64M-$6.07M-$13.74M-$8.66M-$4.56M-$1.21M$564.3K$910.6Kn/a-$535.0K
EPS (Diluted)n/a-$0.06-$0.13-$0.30-$0.19-$0.10-$0.03$0.01$0.02n/a-$0.01
Total Assets$27.96M$28.20M$27.22M$28.46M$42.33M$41.29M$39.92M$13.88M$10.55M$9.28M$8.17M
Total Liabilities$9.91M$11.15M$10.40M$8.11M$11.01M$4.79M$3.76M$2.65M$1.58M$1.61M$1.49M
Shareholders' Equity$18.05M$17.05M$16.81M$20.35M$31.33M$36.50M$36.16M$11.24M$8.96M$7.67M$6.68M
Cash & Equivalents$8.29M$8.87M$9.58M$11.48M$17.41M$25.33M$27.32M$5.87M$3.74M$3.97M$3.31M
Operating Cash Flow$1.39M$462.4K-$319.7K-$4.89M-$5.40M-$4.32M-$743.3K$320.6K$1.48Mn/a-$331.6K
Capital Expenditures$614.3K$932.5K$1.30M$782.9K$2.76M$346.2K$920.6K$201.2K$297.0Kn/an/a
Free Cash Flow$776.7K-$470.1K-$1.62M-$5.68M-$8.17M-$4.67M-$1.66M$119.4K$1.18Mn/an/a
Share Repurchasesn/an/an/an/an/an/an/a$2.8Kn/an/an/a
Shares Outstanding46.15M46.37M45.96M45.67M45.44M44.62M43.26M39.50M38.20M37.99M37.82M
Weighted Average Diluted Sharesn/a46.19M45.80M45.60M45.00M44.39M41.93M39.06M38.92Mn/a37.88M
EPS (Basic)n/a-$0.06-$0.13-$0.30-$0.19-$0.10-$0.03$0.01$0.02n/a-$0.01

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView